In April SLA announced the appointment of Dr Victoria Gorbacheva (formerly of the Menarini Group) to lead the sales and marketing in Russia. Then the Opes mess happened distracting us. The Russian team (I assume lead by Dr Gorbacheva?)has had six months to demonstrate Ropren and build a significant sales pipelene. Hence the phrase 'volume sales'? I hope so.
- Forums
- ASX - By Stock
- announcement ropren pricing updat
In April SLA announced the appointment of Dr Victoria Gorbacheva...
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some